Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilfried Roth

Showing results (161-170 of 196) with videos related to

Pageof 20
Sort By:
Gastroenterology|March 13, 2018
High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic SyndromeLaura Paleari, Jürgen Burhenne, Johanna Weiss, et al.
The Journal of Urology|October 22, 2011
A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusionBoris A Hadaschik, Timur H Kuru, Corina Tulea, et al.
Cancers|January 21, 2022
Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable OutcomeDirk Andreas Ridder, Lana Louisa Urbansky, Hagen Roland Witzel, et al.
Epigenetics|April 2, 2019
Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancerSonja Neumeyer, Odilia Popanda, Dominic Edelmann, et al.
Clinical Epigenetics|July 26, 2019
A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survivalMin Jia, Yan Zhang, Lina Jansen, et al.
BMC Cancer|December 6, 2018
The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patientsMarilena Petrera, Laura Paleari, Matteo Clavarezza, et al.
Translational Oncology|December 23, 2015
Prognostic Significance and Functional Role of CEP57 in Prostate CancerJosef Mang, Nina Korzeniewski, Dimo Dietrich, et al.
Nature Medicine|January 9, 2023
Multistain deep learning for prediction of prognosis and therapy response in colorectal cancerSebastian Foersch, Christina Glasner, Ann-Christin Woerl, et al.
Cancers|June 2, 2021
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile CancerAnita Thomas, Sascha Reetz, Philipp Stenzel, et al.
Translational Oncology|May 1, 2025
Identification and external validation of tumor DNA methylation panel for the recurrence risk stratification of stage II colon cancerTanwei Yuan, Dominic Edelmann, Víctor Moreno, et al.
Pageof 20

Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Gastroenterology|March 13, 2018
High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic SyndromeLaura Paleari, Jürgen Burhenne, Johanna Weiss, et al.
The Journal of Urology|October 22, 2011
A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusionBoris A Hadaschik, Timur H Kuru, Corina Tulea, et al.
Cancers|January 21, 2022
Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable OutcomeDirk Andreas Ridder, Lana Louisa Urbansky, Hagen Roland Witzel, et al.
Epigenetics|April 2, 2019
Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancerSonja Neumeyer, Odilia Popanda, Dominic Edelmann, et al.
Clinical Epigenetics|July 26, 2019
A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survivalMin Jia, Yan Zhang, Lina Jansen, et al.
BMC Cancer|December 6, 2018
The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patientsMarilena Petrera, Laura Paleari, Matteo Clavarezza, et al.
Translational Oncology|December 23, 2015
Prognostic Significance and Functional Role of CEP57 in Prostate CancerJosef Mang, Nina Korzeniewski, Dimo Dietrich, et al.
Nature Medicine|January 9, 2023
Multistain deep learning for prediction of prognosis and therapy response in colorectal cancerSebastian Foersch, Christina Glasner, Ann-Christin Woerl, et al.
Cancers|June 2, 2021
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile CancerAnita Thomas, Sascha Reetz, Philipp Stenzel, et al.
Translational Oncology|May 1, 2025
Identification and external validation of tumor DNA methylation panel for the recurrence risk stratification of stage II colon cancerTanwei Yuan, Dominic Edelmann, Víctor Moreno, et al.
Pageof 20